Drugs / 1,3-BUTANEDIOL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05501366 | Jun 2023 → Oct 2026 expected | disorder of fatty acid and ketone body metabolism | Ohio State University | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 1,3-BUTANEDIOL | ChEMBL registry synonym — accepted as the source's own label CHEMBL1231501 ↗ |
| Known as | (R) 1,3 Butanediol | “BHB Monoester, C8 Diester, and (R) 1,3 Butanediol are commercially available in the products 'deltaG' (TdeltaS Global, FL, USA), 'Cognitive Switch' (Juvenescence Ltd, NJ, USA)...” NCT05501366 ↗1“(R)-1,3 butanediol 180mg/kg” NCT05501366 ↗ |
| Modality | Small molecule | — CHEMBL1231501 ↗ |